Literature DB >> 30587286

Treatment recommendations for trichomoniasis in women.

Patricia Kissinger1, Christina A Muzny2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30587286      PMCID： PMC7265980          DOI： 10.1016/S1473-3099(18)30720-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  6 in total

1.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

2.  New treatment recommendations for trichomoniasis in women.

Authors:  Zhen-Zhou Luo; Yu-Mao Cai; Xiang-Sheng Chen
Journal:  Lancet Infect Dis       Date:  2018-12       Impact factor: 25.071

Review 3.  Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis.

Authors:  Katharine Howe; Patricia J Kissinger
Journal:  Sex Transm Dis       Date:  2017-01       Impact factor: 2.830

4.  Duration of polymerase chain reaction-detectable DNA after treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections in women.

Authors:  James A Williams; Susan Ofner; Byron E Batteiger; J Dennis Fortenberry; Barbara Van Der Pol
Journal:  Sex Transm Dis       Date:  2014-03       Impact factor: 2.830

5.  Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women.

Authors:  Patricia Kissinger; W Evan Secor; Jami S Leichliter; Rebecca A Clark; Norine Schmidt; Erink Curtin; David H Martin
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

6.  Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.

Authors:  Patricia Kissinger; Christina A Muzny; Leandro A Mena; Rebecca A Lillis; Jane R Schwebke; Laura Beauchamps; Stephanie N Taylor; Norine Schmidt; Leann Myers; Peter Augostini; William E Secor; Martina Bradic; Jane M Carlton; David H Martin
Journal:  Lancet Infect Dis       Date:  2018-10-05       Impact factor: 25.071
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.